About this Research Topic
The recent extraordinary COVID-19 epidemics pushed the awareness of acute kidney injury and renal support devices to the forefront of medical practitioners, especially those practicing in the critical care environment. Technologies, which were relatively rarely used before, like extracorporeal membrane oxygenators became now more commonly used. Capacities for continuous kidney support platforms have been exhausted and called for out-of-box thinking to address sudden surges of clinical needs.
Nonetheless, perhaps the most important lesson learned from the event through 2020-2023, is the extraordinary vulnerability to simultaneous impairment of kidney and lung functions in the victims.
This issue wishes to explore the international experience with COVID-19 epidemics and its nephrology the implication in the critically ill and Intensive Care Unit settings. We specifically seek papers from broad world-wide background or exploring new methods of risk stratification, prediction models and
therapeutic intervention, as how they address simultaneous impairment of lung and kidney functions, including those with pre-existing kidney disease.
Specifically, we are now seeking papers on the following key themes:
1.) Indications, timing, implementation, and prognosis for critically ill with kidney injury receiving kidney replacement therapy during the COVID epidemic
2) Opportunities for incremental improvement of conventional multidisciplinary treatments in acute kidney injury, or those with baseline chronic kidney disease
3) Predictive analytics and early intervention for ICU patients with or at risk for renal dysfunctions.
4.) Utilization of artificial intelligence and machine learning methods
4) Application of advanced blood purification techniques to address risk for lung and renal dysfunctions.
5) Renal support in the critical care setting and the interface with complex technologies simultaneously
We believe the Frontiers series is specifically suited to address newly evolving and in-flux paradigms, whereas the COVID epidemics enables us to be better prepared for future similar events if learned lesions well-articulated from the recent epidemics.
Nonetheless, perhaps the most important lesson learned from the event through 2020-2023, is the extraordinary vulnerability to simultaneous impairment of kidney and lung functions in the victims.
This issue wishes to explore the international experience with COVID-19 epidemics and its nephrology the implication in the critically ill and Intensive Care Unit settings. We specifically seek papers from broad world-wide background or exploring new methods of risk stratification, prediction models and
therapeutic intervention, as how they address simultaneous impairment of lung and kidney functions, including those with pre-existing kidney disease.
Specifically, we are now seeking papers on the following key themes:
1.) Indications, timing, implementation, and prognosis for critically ill with kidney injury receiving kidney replacement therapy during the COVID epidemic
2) Opportunities for incremental improvement of conventional multidisciplinary treatments in acute kidney injury, or those with baseline chronic kidney disease
3) Predictive analytics and early intervention for ICU patients with or at risk for renal dysfunctions.
4.) Utilization of artificial intelligence and machine learning methods
4) Application of advanced blood purification techniques to address risk for lung and renal dysfunctions.
5) Renal support in the critical care setting and the interface with complex technologies simultaneously
We believe the Frontiers series is specifically suited to address newly evolving and in-flux paradigms, whereas the COVID epidemics enables us to be better prepared for future similar events if learned lesions well-articulated from the recent epidemics.
Keywords: anticoagulation, artificial intelligence, COVID-19, continuous renal replacement therapy, ECMO/extracorporeal membrane oxygenation, multi-organ failure
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
